ResMed | RMD - Current Liabilities

Stock Price
219.85
Daily Change
0.34 0.15%
Monthly
-2.85%
Yearly
-6.80%
Q2 Forecast
215.15

ResMed reported $1.25B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Ansell USD 468.9M 53.1M Dec/2025
Artivion USD 101.56M 15.72M Dec/2025
AtriCure USD 81.52M 3.68M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Cochlear AUD 558.9M 43.4M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
CSL USD 4.61B 207M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
Fisher Paykel Healthcare NZD 471.3M 29.1M Dec/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Haemonetics USD 539.87M 8.45M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intuitive Surgical USD 2.51B 3.2M Mar/2026
Masimo USD 371.6M 1.9M Dec/2025
Medtronic USD 9.5B 440M Dec/2025
Philips EUR 7.51B 479M Dec/2025
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
Sigma Healthcare AUD 1.7B 1.33B Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Steris USD 922.3M 33.4M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026